Literature DB >> 73852

Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten.

K Sikora, B S Anand, S C Truelove, P J Ciclitira, R E Offord.   

Abstract

Peripheral-blood lymphocytes from patients with coeliac disease showed a marked increase in D.N.A. synthesis after incubation in vitro with a subfraction of gluten. Lymphocytes from control patients showed no increased D.N.A. synthesis under the same conditions. The possible use of this specific lymphocyte-stimulation assay as a screening test for coeliac disease is discussed.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 73852     DOI： 10.1016/s0140-6736(76)92406-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  13 in total

1.  Deficiency of 6B11+ invariant NK T-cells in celiac disease.

Authors:  Randall H Grose; Fiona M Thompson; Adrian G Cummins
Journal:  Dig Dis Sci       Date:  2007-12-13       Impact factor: 3.199

2.  Coeliac disease: A review of the causative agents and their possible mechanisms of action.

Authors:  H J Cornell
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

3.  Specificity of leucocyte migration inhibition test in coeliac disease. A reassessment using different gluten subfractions.

Authors:  G R Corazza; P M Rawcliffe; M Frisoni; P Sarchielli; M Londei; M Campieri; R Lazzari; G Gasbarrini
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

4.  Cell-mediated immunity to gluten fraction III in adult coeliac disease.

Authors:  A W Bullen; M S Losowsky
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

5.  Cellular response to alpha-gliadin in untreated coeliac disease.

Authors:  C O'Farrelly; C Feighery; J F Greally; D G Weir
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

6.  Coeliac disease with severe hypogammaglobulinaemia.

Authors:  A D Webster; G Slavin; M Shiner; T A Platts-Mills; G L Asherson
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

7.  T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC).

Authors:  J O'Keeffe; K Mills; J Jackson; C Feighery
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

8.  Cellular hypersensitivity to a synthetic dodecapeptide derived from human adenovirus 12 which resembles a sequence of A-gliadin in patients with coeliac disease.

Authors:  G J Mantzaris; J A Karagiannis; J D Priddle; D P Jewell
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

9.  Further evidence of a primary mucosal defect in coeliac disease.

Authors:  H J Cornell; C J Rolles
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

10.  Cellular immunity in children with coeliac disease.

Authors:  A Ashkenazi; S Levin; D Idar; Z T Handzel; Y Altman; A Or; N Barzilai
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.